chronic spontaneous urticaria
Conditions
Interventions
Oral treatment group of cyclosporine soft capsules:NA
Sponsors
The First Affiliated Hospital, Zhejiang Univercity School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Clinically confirmed diagnosis of chronic spontaneous urticaria (CSU); 2. Aged between 18–75 years (inclusive), regardless of sex; 3. Normal IgE levels (=16), with persistent symptoms (hives); 4. Receiving cyclosporine (Neoral®) treatment; 5. Willing and able to provide signed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with acute or chronic psychiatric disorders; 2. Patients who had histories of cyclosporine treatments, systemic glucocorticoid therapy within 4 weeks prior to enrollment, or used of other immunosuppressive agents within 3 months before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urticaria activity score 7; | — |
Secondary
| Measure | Time frame |
|---|---|
| Chronic Urticaria Quality of Life Questionnaire;urticaria control test; | — |
Countries
China
Contacts
Public ContactJianjun Qiao
The First Affiliated Hospital of Zhejiang University School of Medicine
Outcome results
None listed